118 related articles for article (PubMed ID: 22997844)
1. Induced pluripotent stem cells for peripheral nerve regeneration.
Xu W; Cox CS; Li Y
J Stem Cells; 2011; 6(1):39-49. PubMed ID: 22997844
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of induced pluripotent stem cell-derived neurospheres for peripheral nerve repair.
Uemura T; Takamatsu K; Ikeda M; Okada M; Kazuki K; Ikada Y; Nakamura H
Biochem Biophys Res Commun; 2012 Mar; 419(1):130-5. PubMed ID: 22333572
[TBL] [Abstract][Full Text] [Related]
3. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
[TBL] [Abstract][Full Text] [Related]
4. A tissue-engineered bioabsorbable nerve conduit created by three-dimensional culture of induced pluripotent stem cell-derived neurospheres.
Uemura T; Takamatsu K; Ikeda M; Okada M; Kazuki K; Ikada Y; Nakamura H
Biomed Mater Eng; 2011; 21(5-6):333-9. PubMed ID: 22561252
[TBL] [Abstract][Full Text] [Related]
5. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
[TBL] [Abstract][Full Text] [Related]
6. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
Nishiyama T; Takeda S
Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
[TBL] [Abstract][Full Text] [Related]
7. [Application of induced pluripotent stem (iPS) cells for nerve injury in the central nervous system].
Kinoshita H
Masui; 2013 Mar; 62(3):259-64. PubMed ID: 23544326
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
López-González R; Velasco I
Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
[TBL] [Abstract][Full Text] [Related]
9. Stem-cell plasticity and therapy for injuries of the peripheral nervous system.
Tohill M; Terenghi G
Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):17-24. PubMed ID: 15270703
[TBL] [Abstract][Full Text] [Related]
10. Role of stem cells in the regeneration and repair of peripheral nerves.
Ren Z; Wang Y; Peng J; Zhao Q; Lu S
Rev Neurosci; 2012 Jan; 23(2):135-43. PubMed ID: 22499672
[TBL] [Abstract][Full Text] [Related]
11. [The stem cells and a problem of regeneration of peripheral nerves].
Diel'tsova OI; Herashchenko SB; Chaĭkovskyĭ IuB
Klin Khir; 2013 Jul; (7):65-8. PubMed ID: 24283050
[No Abstract] [Full Text] [Related]
12. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
Tokumoto Y; Ogawa S; Nagamune T; Miyake J
J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
[TBL] [Abstract][Full Text] [Related]
14. Commercialization challenges associated with induced pluripotent stem cell-based products.
Smith D
Regen Med; 2010 Jul; 5(4):593-603. PubMed ID: 20632862
[TBL] [Abstract][Full Text] [Related]
15. Nestin-positive hair follicle pluripotent stem cells can promote regeneration of impinged peripheral nerve injury.
Amoh Y; Aki R; Hamada Y; Niiyama S; Eshima K; Kawahara K; Sato Y; Tani Y; Hoffman RM; Katsuoka K
J Dermatol; 2012 Jan; 39(1):33-8. PubMed ID: 22098554
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
Song M; Paul S; Lim H; Dayem AA; Cho SG
Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
[TBL] [Abstract][Full Text] [Related]
17. [Research for cell therapy by induced pluripotent stem cell].
Sakurai H; Yamanaka S
Nihon Rinsho; 2011 Dec; 69(12):2114-8. PubMed ID: 22242307
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
19. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
Grabel L
J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325
[TBL] [Abstract][Full Text] [Related]
20. How induced pluripotent stem cells are redefining personalized medicine.
Ferreira LM; Mostajo-Radji MA
Gene; 2013 May; 520(1):1-6. PubMed ID: 23470844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
